Cochlear implants: The eligibility math just changed in your favor

The Charlie Brown teacher on the phone

Dr. Craig Buchman, who heads otolaryngology at Washington University in St. Louis and led the 2020 international consensus statement on adult cochlear implantation, uses a specific analogy for when a hearing aid stops being enough. He points out that hearing aids amplify sound, which works fine when what you need is louder. But as hearing loss deepens, people start losing clarity, not just volume. “Making unclear speech louder does not help with comprehension,” he told WashU Medicine’s news team. “People start to sound like the teacher who mumbles in the Charlie Brown cartoon.”

That is the moment. It is not silence. It is the phone call where your daughter is telling you about something and you can hear that words are being spoken but you cannot resolve them into meaning. It is the restaurant where you keep saying “what” until you give up. It is the volume on the hearing aid cranked to a level that fills your head with noise but still does not deliver the actual sound of a consonant.

Buchman’s number is the one most people find shocking. Less than 10 percent of adults in the United States who would benefit from a cochlear implant have one. “Even though cochlear implants have been approved by the FDA since 1985,” he told WashU, “there may be a misconception that cochlear implants are only for young children born with profound hearing loss.” That misconception is the reason your ENT probably has not brought them up. It is not because you would not qualify. It is because the referral culture has not caught up with the eligibility criteria the FDA and Medicare expanded in 2022.

What changed

Two things changed in the same year and neither got much popular coverage. First, in January 2022, the FDA approved Cochlear Nucleus Implants for unilateral hearing loss and single-sided deafness (SSD), meaning that for the first time, adults with severe or profound loss in one ear and normal or near-normal hearing in the other became eligible for a cochlear implant. Roughly 60,000 US adults acquire SSD every year, often after a sudden hearing loss event or a neurologic cause. Before 2022, their options were a CROS-style hearing aid (which routes signal from the deaf side to the good side) or nothing. Neither restored the ability to localize sound or to hear cleanly in noise. Cochlear implantation on the deaf side does.

Second, in September 2022, the Centers for Medicare and Medicaid Services (CMS) expanded coverage by raising the aided-speech-recognition threshold from 40 percent to 60 percent. This is the technical way of saying that the bar for qualifying dropped meaningfully. The Johns Hopkins Cochlear Implant Center described the CMS change as “a significant improvement in access to care for those with moderate to profound sensorineural hearing loss.” Rough estimate is that 50 percent more adults are now eligible on paper.

The gap between eligibility on paper and referrals in practice is where most patients live. Primary care doctors do not always run comprehensive hearing tests, patients get used to their hearing aid even when it is no longer effective, and ENTs may not be tracking the change. Livium’s read is that if your hearing aid has stopped feeling like enough, the correct next step is a candidacy evaluation at a cochlear implant program, not a stronger hearing aid.

Who qualifies now that did not before

A rough map. Not a diagnostic tool. If any of these rows describe you or someone in your family, ask for the referral.

Source: Livium editorial synthesis of the 2022 FDA approval for single-sided deafness (Cochlear), the September 2022 CMS coverage expansion, and the 2020 international consensus statement in JAMA Otolaryngology led by Dr. Craig Buchman at Washington University.

What the surgery is actually like

This is where the mental model matters. Most patients still picture cochlear implantation as a major operation. It is not. “Cochlear implants can be implanted in an outpatient procedure that typically takes about an hour,” Buchman told WashU. Same-day discharge is common. Recovery is measured in days. Activation happens a few weeks after surgery. Rehabilitation therapy, especially for adults, is important and improves outcomes, but it is auditory training and coaching, not physical rehab in the joint-replacement sense.

The technology itself has also changed. The cochlear implant is no longer just a signal-and-processor system that destroys any residual hearing you had. Modern hybrid electroacoustic systems preserve low-frequency natural hearing in patients who still have some. Newer implants like the Cochlear Nucleus Nexa system (covered in the earlier Livium article on assistive hearing tech) have updatable firmware, so the implant itself receives audio-processing improvements over its lifetime without another surgery. Sound-processor options include off-ear button-style designs that are practically invisible and behind-the-ear designs that are the world’s smallest.

“The Cochlear Nucleus system was FDA-approved for single-sided deafness in January 2022, expanding eligibility to about 60,000 US adults per year. Newer Nexa versions have updatable firmware and Auracast built in.”